Impact of genetics on neoadjuvant therapy with complete pathological response in metastatic colorectal cancer: Case report and review of the literature

Impact of genetics on neoadjuvant therapy with complete pathological response in metastatic colorectal cancer: Case report and review of the literature

Treatment of colorectal metastatic cancer is still challenging, despite recent improvements in chemotherapy. A genetic cancer profile, such as the KRAS (Kirsten rat sarcoma) gene status, plays a key role in individualized tailored therapy. Molecular targeted therapy added to neo-adjuvant chemotherap...

Full description

Bibliographic Details
Main Authors:	Bulajic P, Bidzic N, Djordjevic V, Ceranic Μ, Βasaric D, Pesic V, Djordjevic-Pesic J
Format:	Article
Language:	English
Published:	Sciendo 2019-08-01
Series:	Balkan Journal of Medical Genetics
Subjects:	bevacizumab kras (kirsten rat sarcoma) gene mutation metastatic colorectal cancer pathological complete response vanishing metastases
Online Access:	https://doi.org/10.2478/bjmg-2019-0004

Similar Items

The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer
by: Jisong Zhang, et al.
Published: (2020-02-01)

Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)
by: Bo Peng, et al.
Published: (2017-05-01)

Prognostic value of <it>KRAS </it>genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease
by: Bruera Gemma, et al.
Published: (2012-11-01)

The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy
by: Demiray A, et al.
Published: (2018-12-01)

Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy
by: Guo, W., et al.
Published: (2022)

Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations
by: Afia Muhammad Akram, et al.
Published: (2021-07-01)

CLINICAL EXPERIENCE OF COMBINED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: V. A. Ekimov
Published: (2015-02-01)

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
by: Stein Alexander, et al.
Published: (2012-08-01)

Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
by: M I Sekacheva, et al.
Published: (2013-06-01)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014-07-01)

CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
by: I. S. Bulavina, et al.
Published: (2015-02-01)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
by: Alessandro Ottaiano, et al.
Published: (2021-03-01)

Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review
by: Darius Barimani, et al.
Published: (2020-10-01)

Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
by: I V Poddubnaya, et al.
Published: (2013-03-01)

Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer
by: Hanna Barmettler, et al.
Published: (2012-08-01)

Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
by: Ivana Burazor, et al.
Published: (2018-02-01)

The clone wars - revenge of the metastatic rogue state: the sarcoma paradigm
by: Holly Lynn Spraker, et al.
Published: (2012-01-01)

Relationship between KRAS mutation and diffusion tensor imaging features in brain metastases due to colorectal cancer; preliminary study
by: Mehmet Ali Gultekin, et al.
Published: (2021-09-01)

Pseudoprogression in lung cancer: a case report
by: Giulia Meoni, et al.
Published: (2020-10-01)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014-12-01)

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
by: Ocvirk Janja, et al.
Published: (2016-06-01)

Pathologic Response Rates after Neoadjuvant Therapy for Sarcoma: A Single Institution Study
by: Crystal Seldon, et al.
Published: (2021-03-01)

Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)
by: Gouvas Nikolaos, et al.
Published: (2019-07-01)

Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience
by: Edita Baltruškevičienė, et al.
Published: (2016-04-01)

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab
by: Sergey V. Orlov, et al.
Published: (2020-08-01)

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
by: Pang X, et al.
Published: (2017-05-01)

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis
by: Lauren C. Bylsma, et al.
Published: (2020-02-01)

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research
by: He K, et al.
Published: (2020-12-01)

Das Spiel vom Ende der Zeiten - Ein Künstlerbuch von Jean Kirsten
by: Sauer, Helgard
Published: (2006)

Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
by: Peihang Xu, et al.
Published: (2020-01-01)

Kirsten Sand. Arkitekt for sin tid
by: Elisabeth Seip
Published: (2015-12-01)

Efferent therapy in the first-line drug treatment of metastatic colorectal cancer
by: Z. S. Kotova, et al.
Published: (2018-07-01)

The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
by: I V Poddubnaya, et al.
Published: (2014-03-01)

ANALYSIS OF THE PREVALENCE OF METASTATIC CHOROIDAL LESIONS
by: Ya. V. Parmon, et al.
Published: (2017-01-01)

The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis
by: Xi Zhong, et al.
Published: (2020-05-01)

Metastatic Merkel Cell Carcinoma Resulting in Complete Heart Block
by: Brenden S. Ingraham, MD, et al.
Published: (2020-03-01)

Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review
by: Lianne M. Haveman, et al.
Published: (2020-06-01)

Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
by: Xu R, et al.
Published: (2018-12-01)

Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer
by: Hye-Jin Park, et al.
Published: (2017-08-01)

EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance
by: Jing ZHAO, et al.
Published: (2017-09-01)